paint-brush
Click Here To Claim This Company

BELLUS HEALTH

ninja emoji
employees
light emoji
Since 2010
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.

BELLUS HEALTH

5D1M6Mmax

EVERGREEN INDEX #2364

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Bellus Health

Bellus Health WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!